The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?

Trainor, S; Choudhury, A; Huddart, R; Kiltie, A E; Kockelbergh, R; Turner, W; Birtle, A; Crabb, S J

Trainor, S; Choudhury, A; Huddart, R; Kiltie, A E; Kockelbergh, R; Turner, W; Birtle, A; Crabb, S J.

Afiliação

Trainor S; Department of Medical Oncology, St James's Institute of Oncology, Leeds, UK.
Choudhury A; The Christie NHS Foundation Trust and Manchester Cancer Research Centre, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.
Huddart R; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.
Kiltie AE; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Kockelbergh R; Department of Urology, University Hospitals of Leicester, Leicester, UK.
Turner W; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK.
Crabb SJ; Cancer Sciences Unit, University of Southampton, Southampton, UK. Electronic address: s.j.crabb@southampton.ac.uk.

Clin Oncol (R Coll Radiol) ; 29(6): 344-347, 2017 06.

Article em En | MEDLINE | ID: mdl-28190637

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google